申请人:Molecular Insight Pharmaceuticals, Inc.
公开号:US20140179902A1
公开(公告)日:2014-06-26
Complexes of heterocyclic radionuclides are prepared based upon ligands having substituted pyridyl and imidazolyl groups. The ligands are bifunctional, having amino acid residues that may act as a linker to a bioactive molecule, and a tridentate chelator that may complex the radionuclide. The bioactive molecule may be a peptide or somatostatin.
基于具有取代吡啶和咪唑基团的配体制备了杂环放射性核素的配合物。这些配体是双功能的,具有氨基酸残基,可以作为与生物活性分子连接器的作用,以及三齿螯合剂,可以与放射性核素形成配合物。生物活性分子可以是肽或生长抑素。